Kachhadia, M.P. et al. 2026. Sodium-Glucose Co-Transporter 2 Inhibitor Use and Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis and Type 2 Diabetes: A Retrospective Observational Cohort Study Using Real-World Data. Journal of Clinical Medicine Research. 18, 5 (Jan. 2026), 313–325. DOI:https://doi.org/10.14740/jocmr6577.